Ibandronate Beneficial For Patients with Breast Cancer and Bone Metastases in Many Ways
As per a recent study, Ibandronate could prove as an effective treatment for relieving pain and is also safe to use by patients with breast cancer with metastatic bone disease (MBD).
The study conducted by Marcus Schmidt, MD, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany, and colleagues analyzed impact of ibandronate on patients with breast cancer and MBD and suffering from severe pain, using analgesic and also estimated creatinine clearance in them.
There were involved more than 3,500 patients in the study and they were given ibandronate 6 mg IV for three to four weeks or they were put on a daily 50 mg dose of ibandronate. It was found that the problem of severe pain was reduced in around 64% of the total participants.
Dr. Schmidt said, "The data suggest that the analgesic efficacy and renal safety profile of IV and oral formulations of ibandronate seen in phase 3 trials transfers to routine clinical practice under real-life conditions".
Also, treatment with ibandronate made patients to depend less on analgesis and at the end of the study, 57% of the patients shunned using analgesic as compared to 54% who were at the baseline. The renal function was also found to be stable and no affects were casted by ibandronate treatment on them. There were only 7% cases of skeletal-related events (SREs) and the drug was considered as tolerated.
Famed microbiologist Dr. Mark Wainberg, who played...Read More
Microsoft Corp. has claimed that it has already...Read More
Struggling to fight back soaring heroin and HIV...Read More
During the most recent Nintendo Direct, the mobile...Read More
Fresh Express is recalling a limited number of...Read More
Tech giant Google Inc. has plans to introduce a...Read More